Nightingale Health Oyj (HEL:HEALTH)
Finland · Delayed Price · Currency is EUR 0.9780
+0.0180 (1.88%)
At close: Sep 25, 2026
Nightingale Health Oyj Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 5.5 | 4.69 | 4.36 | 4.18 | 2.31 | |
Revenue Growth | 17.24% | 7.69% | 4.21% | 80.80% | 0.35% |
Cost of Revenue | 2.66 | 1.16 | 1.46 | 0.59 | 1.04 |
Gross Profit | 2.84 | 3.54 | 2.9 | 3.59 | 1.28 |
Selling, General & Admin | 8.49 | 8.6 | 8.78 | 9.38 | 6.5 |
Other Operating Expenses | 6.22 | 6.03 | 4.51 | 6.01 | 4.14 |
Operating Expenses | 21.65 | 22.92 | 21.46 | 22.08 | 14.89 |
Operating Income | -18.81 | -19.38 | -18.56 | -18.49 | -13.61 |
Interest Expense | -0.38 | -0.01 | -0.01 | -0 | -0.77 |
Interest & Investment Income | 0.7 | - | - | - | - |
Earnings From Equity Investments | - | -0.04 | -0.03 | -0.03 | -0.02 |
Currency Exchange Gain (Loss) | - | -0.15 | -0.27 | -0.37 | 0.3 |
Other Non Operating Income (Expenses) | 0 | 1.17 | 1.5 | 0.82 | -0.03 |
EBT Excluding Unusual Items | -18.48 | -18.41 | -17.38 | -18.07 | -14.13 |
Gain (Loss) on Sale of Investments | - | - | - | - | -2.07 |
Pretax Income | -18.48 | -18.41 | -17.38 | -18.07 | -16.19 |
Income Tax Expense | -0.01 | 0.05 | 0.09 | 0.01 | -0.1 |
Net Income | -18.47 | -18.46 | -17.46 | -18.08 | -16.09 |
Net Income to Common | -18.47 | -18.46 | -17.46 | -18.08 | -16.09 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 61 | 60 | 60 | 60 | 60 |
Shares Outstanding (Diluted) | 61 | 60 | 60 | 60 | 60 |
Shares Change | 0.98% | 0.01% | - | 0.17% | 44.56% |
EPS (Basic) | -0.30 | -0.31 | -0.29 | -0.30 | -0.27 |
EPS (Diluted) | -0.30 | -0.31 | -0.29 | -0.30 | -0.27 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -11.76 | -12.39 | -10.62 | -8.16 | -8.85 |
Free Cash Flow Per Share | -0.19 | -0.20 | -0.18 | -0.14 | -0.15 |
Gross Margin | 51.67% | 75.39% | 66.45% | 85.89% | 55.17% |
Operating Margin | -341.79% | -412.95% | -425.86% | -442.16% | -588.46% |
Profit Margin | -335.73% | -393.37% | -400.71% | -432.40% | -695.68% |
Free Cash Flow Margin | -213.78% | -263.90% | -243.62% | -195.17% | -382.49% |
EBITDA | -13.99 | -14.5 | -14.06 | -14.96 | -11.53 |
EBITDA Margin | -254.23% | - | - | - | - |
D&A For EBITDA | 4.82 | 4.88 | 4.5 | 3.53 | 2.08 |
EBIT | -18.81 | -19.38 | -18.56 | -18.49 | -13.61 |